Demo   This portal embeds directly into your clinic website. Your branding, your domain, seamless patient experience.
NUYU Health Technologies

Dashboard

Melbourne Cannabis Clinic
CompoundConnect — Consult, prescribe, compound, dispatch, grow. One platform.
Active patients
847
+12.3% vs prior month
Scripts this month
234
+8.7% vs prior month
Revenue MTD
$67,420
+22.1% vs prior month
SAS approval rate
98.2%
+1.4% improvement
Patient pipeline
View all
Sarah M.
Consult
SAS filed
eRx sent
Dispatch
Delivered
James K.
Consult
SAS review
eRx
Dispatch
Delivered
Mina L.
Consult
SAS filed
eRx sent
Dispatch
In transit
Tom B.
Consult
SAS
eRx
Dispatch
Delivered
Quick actions
New script
Start telehealth
File SAS
Add patient
Track order
Run report
Activity
eRx-4821 dispensed. BPC-157 5mg/mL, Sarah M.
2 min ago
SAS-B approval received. THC:CBD 20:5, James K.
18 min ago
New booking. Initial consult, Alex W. Wed 10:30.
42 min ago
AI note generated. Consult #892 auto-summarised.
1 hr ago
Payment $320.00 received. Mina L.
1 hr ago
Pharmacy. Compounding complete, dispatch to Tom B.
3 hrs ago
Compliance
TGA SAS-B
Clear
AHPRA
Verified
S8 Permits
Current
Audit due
14 days
Patient directory
PatientConditionCurrent scriptSASNext appointmentStatus
SM
Sarah Mitchell
PT-00421
Chronic pain THC:CBD 20:5 Oil Approved 12 Mar, 14:30 Active
JK
James Kowalski
PT-00398
Anxiety / PTSD CBD Isolate 100mg/mL Pending 14 Mar, 10:00 Active
ML
Mina Li
PT-00445
Peptide therapy BPC-157 5mg/mL SAS-B auto 18 Mar, 11:15 Active
TB
Tom Brennan
PT-00460
Insomnia THC Flower 22% Indica Approved 20 Mar, 15:00 Active
AW
Alex Wong
PT-00472
Initial assessment -- N/A 22 Mar, 10:30 New
PR
Priya Ramaswamy
PT-00389
Hormone therapy Testosterone Cream 5% Approved 25 Mar, 13:00 Active
eRx prescription builder
CONNECTED TO eRx NETWORK
Patient
Condition
SAS pathway
Priority
Medication
Dosage
Quantity
Repeats
Compounding pharmacy
Delivery
TGA compliant eRx ready AI note attached
Recent prescriptions
ScriptPatientMedicationPharmacyStatusDate
eRx-4821 Sarah Mitchell THC:CBD 20:5 Oil BHC Compounding Dispensed 4 Mar
eRx-4818 Mina Li BPC-157 5mg/mL Custom Compounding In transit 3 Mar
eRx-4815 Tom Brennan THC Flower Indica 22% Astrid Dispensary Dispensed 2 Mar
eRx-4810 Priya Ramaswamy Testosterone Cream 5% BHC Compounding Compounding 1 Mar
SAS submission queue
PatientPathwayProductStatus
James Kowalski SAS-B CBD Isolate 100mg/mL Pending TGA
Alex Wong SAS-C THC:CBD 10:10 Oil Drafting
New patient SAS-B THC Flower Sativa 18% Awaiting consult
SAS automation
Auto-filed this month 89%
Approval rate 98.2%
Avg processing time 1.2 days
One-click SAS
CompoundConnect auto-populates TGA forms from consult notes, patient history, and medication data. Review and submit in seconds.
Today's consultations
TimePatientTypeStatus
09:00 Sarah Mitchell Follow-up Completed Notes
10:30 James Kowalski Initial In progress
13:00 Priya Ramaswamy Script review Scheduled
15:30 Alex Wong Initial assessment Scheduled
AI clinical notes
Auto-generated
Consult #892 / Sarah Mitchell / 09:00 today
Subjective: Patient reports improved pain management with current THC:CBD 20:5 oil. Sleep quality improved from 4/10 to 7/10. No adverse effects reported. Requesting script continuation at same dosage.

Objective: Stable presentation. No signs of dependency or tolerance. VAS pain score reduced from 6 to 3.

Plan: Continue THC:CBD Oil 20:5 at 0.5mL sublingual BD. 5 repeats. Review in 8 weeks. SAS-B renewal auto-filed.
Pharmacy dispatch
OrderPatientProductPharmacyCompoundingDispatchTracking
ORD-1204 Mina Li BPC-157 5mg/mL Custom Compounding Complete In transit AP1284729AU
ORD-1201 Sarah Mitchell THC:CBD 20:5 Oil BHC Compounding Complete Delivered Confirmed
ORD-1198 Priya Ramaswamy Testosterone Cream 5% BHC Compounding In progress Pending --
ORD-1195 Tom Brennan THC Flower Indica 22% Astrid Dispensary Complete Delivered Confirmed
Monthly revenue
12 months
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Ads and conversion funnel
Google Ads impressions24,320
Website visits3,847
Bookings made412
Consultations completed234
Scripts dispensed198
CPA $47.20 ROAS 6.8x LTV $2,140